Deep Liver Phenotyping and Immunology Study

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 12, 2021

Primary Completion Date

October 31, 2040

Study Completion Date

October 31, 2040

Conditions
Hepatocellular CarcinomaCholangiocarcinoma
Trial Locations (1)

OX3 9DU

RECRUITING

John Radcliffe Hospital, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER